Predictors of residual tumor in breast-conserving therapy

Breast-conserving therapy is considered to be the standard treatment for early breast tumors (T1-T2). In up to 82 % of breast-conserving surgery, tumor cells were still found to be present at or near the cut edge of the surgical specimen after surgery. Thus, it is of clinical need to identify tumors...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Rath, Michèlle Geneviève (VerfasserIn) , Uhlmann, Lorenz (VerfasserIn) , Heil, Jörg (VerfasserIn) , Domschke, Christoph (VerfasserIn) , Roth, Zdravka (VerfasserIn) , Sinn, Peter (VerfasserIn) , Marmé, Frederik (VerfasserIn) , Scharf, Alexander (VerfasserIn) , Schneeweiss, Andreas (VerfasserIn) , Kieser, Meinhard (VerfasserIn) , Sohn, Christof (VerfasserIn) , Rom, Joachim (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 30 July 2015
In: Annals of surgical oncology
Year: 2015, Jahrgang: 22, Heft: 3, Pages: 451-458
ISSN:1534-4681
DOI:10.1245/s10434-015-4736-4
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1245/s10434-015-4736-4
Volltext
Verfasserangaben:Michelle G. Rath, Lorenz Uhlmann, Joerg Heil, Christoph Domschke, Zdravka Roth, Hans-Peter Sinn, Frederik Marme, Alexander Scharf, Andreas Schneeweiss, Meinhard Kieser, Christof Sohn, and Joachim Rom
Beschreibung
Zusammenfassung:Breast-conserving therapy is considered to be the standard treatment for early breast tumors (T1-T2). In up to 82 % of breast-conserving surgery, tumor cells were still found to be present at or near the cut edge of the surgical specimen after surgery. Thus, it is of clinical need to identify tumors at high probability for reexcision in the preoperative setting.
Beschreibung:Gesehen am 10.06.2020
Beschreibung:Online Resource
ISSN:1534-4681
DOI:10.1245/s10434-015-4736-4